“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto….
epilepsy
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly….
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple…
Xphyto Therapeutics (XPHY.C) announced today that they advancing its thin film CBD delivery system for epilepsy sufferers to clinical trials. In the past three months, the company’s German subsidiary,…
Xphyto (XPHY.C) is dominating the cannabis sector like Sean Kemp used to dominate the Seattle buffet scene. It’s a legit beast right now, jumping from fat new high to…
GW Pharmaceuticals (GWPH.Q) has received a recommendation from the European Medicines Agency (EMA) for the authorization of the company’s Epidyolex cannabis oral solution for use in the treatment of…
We have a 60-year-old friend with a torn-up knee who works in a lumber yard in Princeton, BC. At the end of every shift, he ices his knee and…